SynthesisJournal of cancer survivorship : research and practice2026
Internet-based cognitive behavioral therapy for anxiety and depression in breast cancer survivors: a meta-analysis.
Synthesis in Journal of cancer survivorship : research and practice, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Early identification and prevention of depressive symptoms in breast cancer patients.World journal of clinical oncology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveEvaluating the effects of Internet-based cognitive behavioral therapy (I-CBT) on anxiety and depression in breast cancer (BC) survivors.
methodsSystematic searches were conducted on eight Chinese and English databases from inception to July 20, 2024, for relevant randomized controlled trials. The quality of included trials was evaluated using the Cochrane risk of bias (ROB 2.0) tool, and meta-analysis was conducted using RevMan 5.4 software.
resultsSeven studies, including 1016 BC survivors, were included. This meta-analysis found that I-CBT possessed significant effects on anxiety (SMD = - 0.14, 95% CI (- 0.27, - 0.01), P = 0.03) and depression (SMD = - 0.19, 95% CI (- 0.31, - 0.06), P = 0.003); subgroup analyses revealed that self-guided I-CBT significantly improved depression (SMD = - 0.21, 95% CI (- 0.38, - 0.04), P = 0.02); I-CBT lasting 8-12 weeks was effective for anxiety (SMD = - 0.2, 95% CI (- 0.36, - 0.04), P = 0.02) and depression (SMD = - 0.18, 95% CI (- 0.34, - 0.02), P = 0.02); I-CBT with one session per week was effective for depression (SMD = - 0.16, 95% CI (- 0.3, - 0.01), P = 0.04).
conclusionI-CBT had significant effects on anxiety and depression in BC survivors. The individual factors of a self-guided format, an 8-12 week duration, and one session per week each demonstrated greater efficacy for I-CBT in BC survivors; however, further research is needed to validate our conclusion and the long-term efficacy of I-CBT. IMPLICATIONS FOR CANCER SURVIVORS: I-CBT is advisable for BC survivors because of its significant effectiveness on anxiety and depression, and an autonomous and time-flexibility I-CBT program is recommended.
Indexed as
Identifiers
39656420What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.